Skip to main content
Log in

Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders

  • ORIGINAL PAPER
  • Published:
Social Psychiatry and Psychiatric Epidemiology Aims and scope Submit manuscript

Abstract

Background

Evaluation of symptom presentation and antipsychotic response based on ethnicity in children and adolescents with schizophrenia is limited. The purpose of this naturalistic, retrospective database study was to compare symptom presentation of children and adolescents of different ethnicities with schizophrenia-spectrum disorders, and response to risperidone.

Method

African-American (n = 38), Caucasian (n = 30), or Hispanic (n = 37) youths started on risperidone were eligible. Child Behavior Checklist (CBCL) total, internalizing, and externalizing scores were evaluated at baseline, 90 days, 1 year, and 2 year intervals.

Results

At baseline, Hispanic patients had lower CBCL externalizing scores than African-Americans or Caucasians. African-Americans showed significant differences in CBCL total, internalizing, and externalizing scores at 90 days compared to baseline. Hispanics showed improvement in CBCL internalizing scores over the 2 year period. No significant improvements were observed in Caucasians. African-American patients had significantly lower CBCL total at 90 days compared to Hispanic patients. No significant difference existed in 2 year hospitalization rates between groups.

Conclusions

These findings suggest that ethnicity may play a role in symptom presentation and treatment response to risperidone for children and adolescents with schizophrenia-spectrum disorders. Future studies in children and adolescents are necessary to examine ethnospecific differences in antipsychotic use and treatment response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Fabrega H, Mezzich J, Ulrich JF (1988) African-American – White differences in psychopathology in an urban psychiatric population. Compr Psychiatry 29:285–297

    Article  PubMed  Google Scholar 

  2. Brekke JS, Barrio C (1997) Cross-ethnic symptom differences in schizophrenia: the influence of culture and minority status. Schizophr Bull 23:305–316

    CAS  PubMed  Google Scholar 

  3. Barrio C, Yamada AM, Atuel H, Hough RL, Yee S, Berthot B, Russo PA (2003) A tri-ethnic examination of symptom expression on the positive and negative syndrome scale in schizophrenia spectrum disorders. Schizophr Res 60:259–269

    Article  PubMed  Google Scholar 

  4. Weisman AG, Lopez SR, Ventura J, Nuechterlein KH, Goldstein MJ, Hwang S (2000) A comparison of psychiatric symptoms between Anglo-Americans and Mexican-Americans with schizophrenia. Schizophr Bull 26:817–824

    CAS  PubMed  Google Scholar 

  5. Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, Day R (1986) Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychol Med 16:909–928

    Article  CAS  PubMed  Google Scholar 

  6. Frackiewicz EJ, Sramek JJ, Herrera JM, Kurtz NM, Cutler NR (1997) Ethnicity and antipsychotic response. Ann Pharmacother 31:1360–1369

    CAS  PubMed  Google Scholar 

  7. Collazo J, Tam R, Sramek JJ, Herrera J (1996) Neuroleptic dosing in Hispanic and Asian inpatients with schizophrenia. Mt Sinai J Med 63:310–313

    CAS  PubMed  Google Scholar 

  8. Emsley RA, Roberts MC, Rataemane S, Pretorius J, Oosthuizen PP, Turner J, Niehaus DJH, Keyter N, Stein DJ (2002) Ethnicity and treatment response in schizophrenia: a comparison of 3 ethnic groups. J Clin Psychiatry 63:9–14

    PubMed  Google Scholar 

  9. American Academy of Child, Adolescent Psychiatry (2001) Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 40(suppl 7):4S–23S

    Google Scholar 

  10. Armenteros JL, Whitaker AH, Welikson M, Stedge DJ, Gorman J (1997) Risperidone in adolescents with schizophrenia: an open pilot study. J Am Acad Child Adolesc Psychiatry 36:694–700

    Article  CAS  PubMed  Google Scholar 

  11. Quintana H, Keshavan M (1995) Case study: risperidone in children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 34:1292–1296

    Article  CAS  PubMed  Google Scholar 

  12. Grcevich SJ, Findling RL, Rowane WA, Friedman L, Schulz SC (1996) Risperidone in the treatment of children and adolescents with schizophrenia: a retrospective study. J Child Adolesc Psychopharmacol 6:251–257

    Article  CAS  PubMed  Google Scholar 

  13. Achenbach TM (2000) Child behavior checklists (CBCL/2-3 and CBCL/4-18), Teacher report form (TRF), and Youth self report (YSR). In: Handbook of psychiatric measures. American Psychiatric Association, Washington DC, pp 310–314

  14. Kopelowicz A, Zarate R, Gonzales V, Lopez SR, Ortega P, Obregon N, Mintz J (2002) Evaluation of expressed emotion in schizophrenia: a comparison of Caucasians and Mexican-Americans. Schizophr Res 55:179–186

    Article  PubMed  Google Scholar 

  15. Frackiewicz EJ, Herrera JM, Sramek JJ, Collazo Y, Lawson WB (2002) Risperidone in the treatment of Hispanic inpatients with schizophrenia: a pilot study. Psychiatry 65:371–374

    PubMed  Google Scholar 

  16. Lasser KE, Himmelstein DU, Woolhandler SJ, McCormick D, Bor DH (2002) Do minorities in the United States receive fewer mental health services than whites? Int J Health Serv 32:567–578

    Article  PubMed  Google Scholar 

  17. Cauce AM, Domenech-Rodriguez M, Paradise M, Cochran BN, Shea JM, Srebnik D, Baydar N (2002) Cultural and contextual influences in mental help seeking: a focus on ethnic minority youth. J Consult Clin Psychol 70:44–55

    Article  PubMed  Google Scholar 

  18. Fields JH, Grochowski S, Lindenmayer JP, Kay SR, Grosz D, Hyman RB, Alexander G (1994) Assessing positive and negative symptoms in children and adolescents. Am J Psychiatry 151:249–253

    CAS  PubMed  Google Scholar 

  19. Stratkowski SM, Keck PE, Arnold LM, Collins J, Wilson RM, Fleck DE, Corey KB, Amicone J, Adebimpe VR (2003) Ethnicity and diagnosis in patients with affective disorders. J Clin Psychiatry 64:747–754

    Article  Google Scholar 

  20. Fleischhacker WW, Oehl MA, Hummer M (2003) Factors influencing compliance in schizophrenia patients. J Clin Psychiatry 64(suppl 16):10–13

    PubMed  Google Scholar 

  21. Opolka JL, Rascati KL, Brown CM, Gibson PJ (2003) Role of ethnicity in predicting antipsychotic medication adherence Ann Pharmacother 37:625–630

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nick C. Patel.

Additional information

Location of work: College of Pharmacy, The University of Texas at Austin, TX; Austin State Hospital, Austin, TX; and, Texas Department of State Health Services, Austin, TX.

Supported in part by a Ruth L. Kirschstein NRSA Fellowship sponsored by NIMH (N. Patel) and the Texas Department of State Health Services.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, N.C., Crismon, M.L., Shafer, A. et al. Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders. Soc Psychiat Epidemiol 41, 341–346 (2006). https://doi.org/10.1007/s00127-006-0036-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00127-006-0036-4

Key words

Navigation